Clinical Trial Update: A Study of TL-925 as a Treatment for Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TL-925 in dry eye disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• TL-925

Snippet

Sponsor: Telios Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED